Consensus Elanco Animal Health Incorporated

Equities

ELAN

US28414H1032

Market Closed - Nyse Other stock markets 04:00:04 2024-04-23 pm EDT			5-day change	1st Jan Change
13.46 ^USD	+4.10%		-1.32%	-9.66%

Apr. 01	Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	MT
Apr. 01	Elanco appoints two directors after settling with activist Ancora	RE

Evolution of the average Target Price on Elanco Animal Health Incorporated

Price target over the last 5 years

History of analyst recommendation changes

cdc6a22a5c00ad366e5.0vXE_82V-l9ITuAjOjrSPfMR2dfJL8nTf3EmDFl0HcE.gMGwq5nSsDh5LZd3UQ-rVJF0i72iWb-0TBRUPxBCaKiHk7eSo-aZFzsN2A~50e9784c92f70b8d190aa8bfae94fc70

Analyst Recommendations on Elanco Animal Health Incorporated

Morgan Stanley Adjusts Elanco Animal Health's Price Target to $17 From $16, Keeps Overweight Rating	Feb. 27	MT
Goldman Sachs Raises Price Target on Elanco Animal Health to $14 From $12.50, Maintains Sell Rating	Feb. 27	MT
Barclays Adjusts Price Target on Elanco Animal Health to $19 From $18, Maintains Overweight Rating	Feb. 27	MT
Goldman Sachs Adjusts Elanco Animal Health's Price Target to $12.50 From $10, Keeps Sell Rating	Jan. 17	MT
Stifel Upgrades Elanco Animal Health to Buy From Hold, Raises Price Target Price Target to $20 From $13	Jan. 05	MT
Jefferies Initiates Elanco Animal Health at Buy Rating With $17 Price Target	Dec. 19	MT
Morgan Stanley Upgrades Elanco Animal Health to Overweight From Equalweight, Price Target is $16	Dec. 15	MT
Stifel Trims Price Target on Elanco Animal Health to $12 From $13, Maintains Hold Rating	23-10-30	MT
Piper Sandler Adjusts Price Target on Elanco Animal Health to $13 From $9, Maintains Neutral Rating	23-08-14	MT
Goldman Sachs Adjusts Price Target on Elanco Animal Health to $9.50 From $8.50, Maintains Sell Rating	23-08-08	MT
Piper Sandler Adjusts Elanco Animal Health Price Target to $9 From $12, Maintains Neutral Rating	23-05-15	MT
Goldman Sachs Adjusts Price Target on Elanco Animal Health to $9 From $10.50, Maintains Sell Rating	23-04-25	MT
Barclays Upgrades Elanco Animal Health to Overweight From Equalweight, Price Target is $14	23-04-20	MT
Goldman Sachs Cuts Elanco Animal Health's Price Target to $10.50 From $12, Maintains Sell Rating	23-02-22	MT
Barclays Trims Price Target on Elanco Animal Health to $14 From $18, Keeps Equalweight Rating	23-02-22	MT
Morgan Stanley Adjusts Price Target on Elanco Animal Health to $19 From $20, Maintains Equalweight Rating	23-01-30	MT
Morgan Stanley Adjusts Price Target on Elanco Animal Health to $20 From $21, Maintains Equalweight Rating	22-11-15	MT
Piper Sandler Slashes Price Target on Elanco Animal Health to $15 From $21, Affirms Neutral Rating	22-11-14	MT
JPMorgan Lowers Elanco Animal Health's Price Target to $17 From $20, Maintains Neutral Rating	22-11-09	MT
Goldman Sachs Adjusts Elanco Animal Health Price Target to $12 From $19, Maintains Sell Rating	22-11-09	MT
JPMorgan Chase Lowers Elanco Animal Health's Price Target to $20 From $24, Maintains Neutral Rating	22-10-17	MT
Morgan Stanley Adjusts Elanco Animal Health Price Target to $21 From $22, Maintains Equal Weight Rating	22-10-07	MT
Fitch Affirms Elanco's IDR at 'BB'; Outlooks Remains Negative	22-09-20	AQ
Barclays Adjusts Elanco Animal Health's Price Target to $18 from $32, Reiterates Equalweight Rating	22-09-12	MT
Morgan Stanley Downgrades Elanco Animal Health to Equalweight From Overweight, Cuts Price Target to $22 From $37, Cites Longer 'Constrained' Visibility	22-08-18	MT